RGT 0.00% 30.5¢ argent biopharma limited

Ann: Half Yearly Report and Accounts, page-49

  1. 1,049 Posts.
    lightbulb Created with Sketch. 241
    Hi Zig, you can share if you want to. All I want to share are the facts

    It's quite obvious that "material changes in equity market in US" is definitely look like a lousy excuse to me. Do you (or Roby) know what the "material changes" is?

    As I said, I believed MXC management was also being played in this occasion. Look at what's happened to VC deal, we can all agree the management team seems to be quite inexperience (or invigilant).

    The biggest mistake of MXC in this case was they announced the deal too soon to the shareholders. They should only announce the deal when everything was settled and confirmed. We can see there were a lot of modifications from the first announcement and the following announcement s(e.g. 1 million become 500k, listed become unlisted etc). This definitely give people a very bad and amateur impression.




    Last edited by Sparkz918: 10/03/19
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
0.000(0.00%)
Mkt cap ! $14.00M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 3300 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 313 1
View Market Depth
Last trade - 16.16pm 12/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.